Andrew Scott (mentor: Daniel Wahl, M.D., Ph.D.): F32 ($196K) for “Targeting purine biosynthesis to radiosensitize glioblastoma” (DT)
Lillian Lai, M.D. (mentors: Ganesh Palapattu, M.D.; Brent Hollenbeck, M.D.): "Understanding Active Surveillance for Prostate Cancer." Journal of Clinical Oncology-Oncology Practice. (TACR, CEP)
Nicole Grogan, M.D. (mentor: N. Lynn Henry, M.D., Ph.D.): Conquer Cancer – Rising Tide Foundation for Clinical Cancer Research Career Pathway Grant in Symptom Management. “A Single Center Phase 2 Trial to Evaluate Use of Cannabidiol (CBD) to Treat Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS) in Early Stage Breast Cancer Patients” (TACR)
Kenneth Trieu (mentor: Sunny Wong, Ph.D.): NCI F31 ($113K) for “Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis” (CB)
Elizabeth Gensterblum-Miller (mentor: Chad Brenner, Ph.D.): NIDCR F31 ($113K) for “Analysis of the E7-Mediated Mechanism of MHC Class I Repression in HNSCC” (TACR)
Andrea Pesch (mentors: Corey Speers M.D., Ph.D. and James Rae, Ph.D.): NCI F31 ($112K): "Elucidating the Mechanism of CDK4/6 Inhibitor-Mediated Radiosensitization of ER+ Breast Cancers" (TACR)
Jennifer Jiménez (mentors: Elizabeth Lawlor, M.D., Ph.D. and Costas Lyssiotis, Ph.D.): F31 ($113K) "Defining the role of menin in the Ewing sarcoma stress response" (CB)
Sho Kitamoto, Ph.D. (mentors: Eric Fearon, M.D., Ph.D., and Nobuhiko Kamada, Ph.D.): $562K DoD Peer Reviewed Cancer Research Program Career Development Award for “The role of oral genotoxic bacteria in the development of colon cancer” (CG, CB)
Steven Kregel, Ph.D. (mentor: Arul Chinnaiyan, M.D., Ph.D.) and Jean Tien, Ph.D.: $583K Bristol-Myers Squibb Company for “Evaluating the effect of BMS BET inhibitor (BMS-986158) on AR signaling and its combination efficacy with AR antagonists in prostate cancer models” (CG, TACR)
Brittany Morgan, Ph.D. (mentor: Anna Mapp, Ph.D.): NIGMS F32 ($130K) "Molecular Recognition Frameworks for Fuzzy Protein-Protein Interactions" (DT)
Christopher Halbrook, Ph.D., a mentee of Costas Lyssiotis, Ph.D., earned an NIH K99 grant for his work on disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer.
Samuel Kerk (Mentor: Costas Lyssiotis, Ph.D.): F31 ($111K) "Metabolic interactions in the pancreatic tumor microenvironment" (CB)
Mengrou Shan (Mentor: Costas Lyssiotis, Ph.D.): F32 ($187K) "Defining and targeting malic enzyme dependence in pancreatic cancer" (CB)
Chan Chung (mentor: Sriram Venneti, M.D., Ph.D.): $148K from the Michael Mosier Defeat DIPG Foundation and ChadTough Foundation for "Targeting DIPGs by interrupting metabolic pathways" (CG)
Janggun Jo (mentor—Xueding Wang, PhD): $225K Prostate Cancer Foundation Young Investigator Award for “Evaluating Prostate Cancer by Functional Photoacoustic Imaging with Nanoprobe” (TACR)
Andrea Pesch and Anna Michmerhuizen (co-first authors; mentor - Corey Speers, MD, PhD): "PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation," Molecular Cancer Therapeutics.
Abhijit Parolia (mentor- Arul Chinnaiyan, MD, PhD): NIBIB K01 ($492K) “Chimeric Antigen Receptor T Cell Design Through Living Cell Systems Biology” (CB) : Predoctoral to Postdoctoral Fellow Transition, F99/K00 ($76K), "Exploring mechanisms of transcriptional and chromatin dysregulation in cancer"
Peter Kim (mentor-Costas Lyssiotis, PhD): F31 ($113K) “Metabolism of extracellular matrix supports pancreatic cancer growth” (CB)
Sophia Orbach (mentor-Lonnie Shea, PhD): F32 ($187K) “Heterogeneity of the early metastatic niche in cancer progression and chemoresistance” (CB)
Joseph Decker (mentor- Lonnie Shea, PhD): NIBIB K01 ($492K) “Chimeric Antigen Receptor T Cell Design Through Living Cell Systems Biology” (CB)
Peter Kim (mentor - Ormand MacDougald, PhD): F31 ($112K) “CRISPR/Cas9 Somatic Mutagenesis in Adipose Tissue” (CB)
Other External Grants
Steven Kregel (mentor Arul Chinnaiyan, MD, PhD): $225K Young Investigator Award from the Prostate Cancer Foundation for “Employing Murine Models with Humanized Immune Systems to Study Therapeutic Approaches for Advanced Prostate Cancer” (CG/TACR)
Maria Garcia Fabiani (mentor - Maria Castro, PhD): $100K Basic Research Fellowship from the American Brain Tumor Association for “Impact of H3G34R mutation in reprogramming the glioma immune microenvironment” (CHI)